Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dyax Corp (NASDAQ:DYAX)

24.03
Delayed Data
As of Jul 30
 -0.23 / -0.95%
Today’s Change
8.83
Today|||52-Week Range
30.55
+70.91%
Year-to-Date

Today’s Trading

Previous close24.26
Today’s open23.75
Day’s range-- - --
Volume1,304,960
Average volume (3 months)1,003,133
Market cap$3.5B
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)+65.38%
Earnings growth (this year)-112.50%
Earnings growth (next 5 years)+30.66%
Revenue growth (last year)+51.55%
P/E ratioNM
Price/Sales22.95
Price/Book31.34

Competitors

 Today’s
change
Today’s
% change
CRLCharles River Labora...-2.08-2.72%
PRXLPAREXEL Internationa...-0.54-0.78%
INCRINC Research Holding...+4.46+10.33%
PRAHPRA Health Sciences ...+0.29+0.69%
Data as of 07/30/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$81.7M
Annual profit (last year)-$11.9M
Net profit margin-14.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts